Use of CDNA Microarrays to Estimate Gene Modulation Profiles Induced by Zoledronic Acid Treatment in Androgen-Resistant Prostate Cancer Cell Line (PC3). Hematol Meeting Rep 2009, 2 (3). https://doi.org/10.4081/hmr.v2i3.365.